Mouse monoclonal antibody against Actin (SM) (Clone ISM097)
Mouse monoclonal antibody against Actin (SM) (Clone ISM097)
Figure 1 Human breast cancer stained with anti Actin(SM) antibody (ISM097).
Product identification
ISC002-R3 3 ml ready-to-use (RTU)
ISC002-R7 7 ml ready-to-use (RTU)
ISC002-C02 0.2 ml concentrated
ISC002-C05 0.5 ml concentrated
Summary and explanation
Actin(sm) ( alpha-smooth muscle actin), which is the actin isoform that predominates within vascular smooth muscle cells and coordinately regulated by tgf1. Actin(sm) is a cytoskeletal protein that is localized in vascular smooth muscle cells and pericytes , as well as some stem cells and precursor cells. This protein is also known as a marker of myofibroblast an important role in fibrogenesis , which are found in various tissues during tissue repair and regeneration following injury. Cells with a-sma-positive fibers in the interstitium, except for the vascular components, have been recognized to be myofibroblasts.
Principle of the procedure
The stated primary antibody is suitable forimmunohistochemical staining of ffpe tissue sectionsbased on specific antigen-antibodyantibody reaction. Using adetection system linked to hrp or alkalinephosphatase the antigen visualization is performed viaspecific binding of the primary antibody. Secondaryantibody is binding to the primary antibody, and theenzyme complex labels this complex. The enzymaticactivation of the chromogen results in a visible reactionproduct at the antigen site. Each step is incubated for aprecise time and temperature and requires interposedwashing steps. The specimen may then becounterstained. Results are interpreted using a lightmicroscope.
Staining procedure
- Cut 3-4 μm section of formalin-fixed paraffin-embedded tissue and place on positively charged slides.
- Dry at 65°C for 2 hours
- Deparaffinize, rehydrate, and epitope retrieve. Upon completion, rinse with 3 changes of distilled or deionized water.
- If using HRP detection system, place slides in peroxide block for 10 minutes; rinse. If using AP detection system, omit this step.
- Apply the antibody and incubate for 60 minutes; rinse.
- Apply the InSituVison™ Polymer Rabbit/Mouse Detection System for 30 minutes; rinse.
- Apply ample amount of DAB or AEC chromogen and incubate; rinse.
- Dehydrate and coverslip.
Interpretation of results
Interpretation of resultsthe immunostaining procedure causes a coloredreaction product to precipitate at the antigen siteslocalized by the primary antibody.
Cellular localization: cytoplasm.
A qualified pathologist experienced in immunohistochemistry procedures must evaluate positive and negative tissue controls before interpreting patient specimens. Positive staining intensity should be assessed withinthe context of any background staining oof the negativereagent control. Note: a negative result means that the antigen inquestion was not detected, but not that the antigen isnot present in the cells/tissues tested. An antibodypanel may be used to support the results in somecircumstances. Additionally, ditionally, the morphology of eachtissue sample should be examined utilizing ahematoxylin and eosin stained section. A qualifiedpathologist must interpret the patients morphologicfindings and pertinent clinical data.
Warnings and precautions
1. Application only by qualified and trained personnel.
2. There are no estimated health risks, if the productis used as directed. Msds is available on request.
3. Product contains sodium azide as preservative. Pure sodium azide is toxic. The concentration ofsodiumum azide in this reagent is < 0.1 % and is notclassified hazardous. See msds.
4. Ass with any product derived from biologicalsources, proper handling procedures should beused.
5. Do not use reagents after expiration date.
6. Take reasonable precautions when handlhandlingreagents. Use protective clothing and gloves.
7. All hazardous materials should be disposedaccording to guidelines for hazardous wastedisposal. Materials of human or animal originshould be handled as biohazardous materials anddisposed of with proper precautions.
8. Avoid microbial contamination of reagents as itmay cause incorrect results.
Materials provided
| Primary antibody | Actin (SM) |
| Host | Mouse |
| Subclass | IgG |
| Clone | ISM005 |
| Species Cross-reactivity | Human. Others-not known |
| Applications | Immunohistochemistry |
| Epitope Retrieval | Heat-induced epitope retrieval |
| Ready-to-use antibody | Prediluted antibody in antibody diluent buffer |
Product label shows the specific lot number.
Prediluted antibody is ready-to-use and optimized for staining. No further dilution, reconstitution, mixing, or titration is needed.
Materials required but not provided
The following materials may be required for staining but are not provided with the primary antibody.
– Positive and negative controls
– Microscope slides (positively charged) and cover slips
– Water bath
– Humidified chamber
– Staining jars
– Stopwatch
– Xylene or xylene substitute
– Ethanol
– Deionized or distilled water
– Antigen retrieval reagent, e.g. Antigen Enhancer (HIER buffer), Cat. No. BUAN01-500
– Detection system, e.g. IHC Complete Detection system (Goat anti mouse/rabbit HRP, DAB staining), Cat. No. D001-15
– Wash buffer: e.g. IHC Wash Buffer, Cat. No. BUWA01-1000
– Tap water/bluing reagent (e.g. ammonia water)
– Light microscope
Storage and handling
Store at 2 – 8 °C.
When stored correctly antibody is stable to the expiration date indicated on the vial. Do not use after expiration date.
To ensure proper reagent delivery and stability of the antibody, replace the dispenser cap after every use and immediately place the bottle cool in an upright position.
Literature
[1] Yoshiba N, Yoshiba K, Ohkura N, et al. Immunohistochemical analysis of two stem cell markers of α-smooth muscle actin and STRO-1 during wound healing of human dental pulp[J]. Histochemistry and cell biology, 2012, 138: 583-592 .
[2] Annegowda VM, Devi HSU, Rao K, et al. Immunohistochemical study of alpha-smooth muscle actin in odontogenic cysts and tumors[J]. Journal of Oral and Maxillofacial Pathology: JOMFP, 2018, 22(2): 188-192.
Date of publication or revision
2024-06-10
Change(s) made: –
Explanation of symbols
